Morbidity of antireflux surgery in lung transplant and matched nontransplant cohorts is comparable.
Deepika RaziaSumeet K MittalRajat WaliaSofya TokmanJasmine L HuangMichael A SmithRoss M BremnerPublished in: Surgical endoscopy (2022)
Despite a higher perceived risk of comorbidity burden, LT recipients and matched NT controls had similar rates of post-LARS 30-day morbidity at our large-volume center with expertise in transplant and foregut surgery. LARS after LT is safe.